English  |  正體中文  |  简体中文  |  Items with full text/Total items : 43238/136796
Visitors : 2055989      Online Users : 118
RC Version 3.1 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://ntur.lib.ntu.edu.tw/handle/246246/169122

Title: Ascorbate Supplement Reduces Oxidative Stress in Dyslipidemic Patients Undergoing Apheresis
Authors: 鄭劍廷;張維典;陳惠文;王宗道;劉紹毅;陳再晉;張炎林;李源德;許世明
CHIEN, CHIANG-TING;CHANG, WEI-TIEN;CHEN, HUEI-WEN;WANG, TZUNG-DAU;LIOU, SHAW-YIH;CHEN, TZAY-JINN;CHANG, YEN-LIN;LEE, YUAN-THE;HSU, SU-MING
Contributors: 醫學研究部
Date: 2004
Issue Date: 2009-09-30T07:34:02Z
Abstract: Objective - The effect of ascorbate treatment on apheresis- induced oxidative stress in uremic and dyslipidemic patients was evaluated. Methods and Results - We developed a chemiluminescence-emission spectrum and high-performance liquid chromatography analysis to assess the effect of ascorbate supplement on plasma reactive oxygen species (ROS) scavenging activity and oxidized lipid/protein production in hyperlipidemic and uremic patients undergoing apheresis. Apheresis was efficient in reduction of atherogenic lipoproteins, complement, fibrinogen, soluble intercellular adhesion molecule-1, and oxidative parameters including phosphatidylcholine hydroperoxide (PCOOH), malonaldehyde, methylguanidine, and diotyrosine. Apheresis itself, however, activated leukocytes to increase ROS activity and reduced the plasma ROS scavenging activity. Ascorbate administration selectively diminished apheresis-enhanced H2O2 and inflammatory mediators such as tumor necrosis factor alpha ( TNF-alpha ) and monocyte chemoattractant protein-1. Chronically dyslipidemic and uremic patients undergoing biweekly apheresis plus ascorbate treatment had lower levels of C-reactive protein and PCOOH than did those without ascorbate treatment during a 6-month follow-up study period. Conclusions - We demonstrate that apheresis with ascorbate treatment provides a therapeutic potential in reducing atherosclerotic risk via inhibition of H 2O2-induced oxidative stress in patients with uremia or dyslipidemia.
Relation: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY v.24 n.6 pp.1111-1117
Appears in Collections:[附設醫院醫學研究部] Periodical Articles

Files in This Item:

There are no files associated with this item.



All items in NTUR are protected by copyright, with all rights reserved.

 

DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team  - Feedback